Latest updates for Aubagio

Fresh curated links around Aubagio are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Briumvi outperforms Aubagio when given as first MS therapy, per trial data
  • CMSC 2026: Kesimpta outperforms Aubagio in highly active relapsing MS
  • Treatments (Part 5).Who is using alemtuzumab?

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

multiplesclerosisnewstoday.com /1 month ago

Briumvi outperforms Aubagio when given as first MS therapy, per trial data

First-line treatment with TG Therapeutics’ Briumvi (ublituximab) in clinical trials among people with relapsing forms of multiple sclerosis (MS) led to significantly fewer relapses...

Read source
multiplesclerosisnewstoday.com /1 month ago

CMSC 2026: Kesimpta outperforms Aubagio in highly active relapsing MS

Kesimpta (ofatumumab) was more effective than Aubagio (teriflunomide) at suppressing disease activity in people with highly active, relapsing forms of multiple sclerosis (MS), acco...

Read source
multiple-sclerosis-research.org /1 week ago

Treatments (Part 5).Who is using alemtuzumab?

So we will do the drug use of alemtuzumab today for year 2025-2026 so down load the 12 CSV files for April-2025-March 2026. I have selected alemtuzmab as this will be the quickest...

Read source
multiplesclerosisnewstoday.com /1 week ago

Mavenclad may pull double duty for MS and other autoimmune conditions

In addition to controlling multiple sclerosis (MS), the approved therapy Mavenclad (cladribine) may also help manage certain coexisting autoimmune diseases, potentially allowing so...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Start creating posts

Sources covering Aubagio

multiple-sclerosis-research.org

Recent coverage from public sources
Public source

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source

Related searches

News Archive Aubagio CMSC Annual Meeting Mavenclad briumvi clinical trials comorbidities treatment

Recent searches

Artificial Intelligence Machine Learning Data Science Data Engineering Business Intelligence Web Development Software Development Software Testing Programming JavaScript DevOps Cyber Security Product Management Project Management Design UX UX Research Graphic Design Video Production Video Editing